Citation only
via OpenAlex
Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors
Ma. Eugenia Garay‐Sevilla, Juan Manuel Malacara, A. Gutiérrez‐Roa, ez Fernando Lavalle González
Diabetic Medicine · 1999 · ▲ 56 citations
Abstract
AIMS: We have investigated denial of disease in patients with Type 2 diabetes mellitus (DM) and its possible association with metabolic control, and with psychosocial variables: satisfaction with medical care, perceived stress, social support, knowledge of diabetes and belief in conventional medicine. METHODS: We studied 160 patients in a cross-sectional design, in two groups: with (70) and without social security coverage (90). The mean age for the total group was 53.6 years, with a known diabetes duration of 8.1 years. RESULTS: Denial of disease was similar in those with < or = 5 years since diagnosis (73 patients) and with > 5 years (87). The group without social security had higher scores of perceived stress, and lower scores of social support, knowledge about diabetes and belief in conventional medicine; denial, however, was similar in the two groups with or without social security. Multiple regression analysis showed that denial of disease was positively associated with HbA1c in the total group (P < 0.001), in the groups with < or = 5 and > 5 years since diagnosis, as well as in the groups with or without social security. Denial was also associated with years since diagnosis (P = 0.009) for the group with < or = 5 years since diagnosis. CONCLUSIONS: We concluded that, in patients with Type 2DM denial of disease increases with time during the first 5 years of evolution of diabetes; is associated with poor metabolic control; but is not associated with knowledge of diabetes, belief in conventional medicine, social support or perceived stress.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1046/j.1464-5491.1999.00033.x
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Garay‐Sevilla, M.E., Malacara, J.M., Gutiérrez‐Roa, A., & González, E.F.L. (1999). Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors. <em>Diabetic Medicine</em>. https://doi.org/10.1046/j.1464-5491.1999.00033.x
Vancouver
Garay‐Sevilla ME, Malacara JM, Gutiérrez‐Roa A, González EFL. Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors. Diabetic Medicine. 1999. doi:10.1046/j.1464-5491.1999.00033.x.
BibTeX
@article{ma1999Denial,
title = {Denial of disease in Type 2 diabetes mellitus: its influence on metabolic control and associated factors},
author = {Ma. Eugenia Garay‐Sevilla and Juan Manuel Malacara and A. Gutiérrez‐Roa and ez Fernando Lavalle González},
journal = {Diabetic Medicine},
year = {1999},
doi = {10.1046/j.1464-5491.1999.00033.x},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes/Metabolism Research and Reviews 2019
Open access · CC-BY
Standards of medical care for type 2 diabetes in China 2019
King Edward Medical University 2026
Open access · US-GOV
Telemedicine-Delivered Nutritional Counseling Versus Standard Care for Cancer Cachexia in Pakistani Cancer Patients: A Pilot Randomized Controlled Trial
Clinical Journal of the American Society of Nephrology 2010
Preprint · OA
Metabolic Basis for Low Urine pH in Type 2 Diabetes
Journal of the American Society of Nephrology 2006
Citation only
Type 2 Diabetes Increases the Risk for Uric Acid Stones
Gali Perel 2026
Open access · US-GOV
CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss
Gender Medicine 2010
Citation only